中
En
Main
Our Service
Focus Area & Strength
Site Management Organization
Facilities
Clinical Trial
What is Clinical Trial
Participant Testimonials
Our Trials
Completed Trials
OnGoing Trials
About Us
Contact Us
Completed Trials
Osteoarthritis
NCT00486434* (SMC021)
NCT01919164* (Sprifemin)
NCT02357459* (FX006)
NCT02683239* (Fasinumab
NCT04333160* (JTA-004)
NCT04506463* (MM-II)
NCT05618782*(LEVI-04)
2019-004515-31* (SB-061)
*only site in Asia
Osteoporosis
NCT00525798 (SMC021)
NCT01343004* (BA058)
NCT01657162* (BA058)
NCT01631214 (Romosozumab)
NCT01575834 (Romosozumab)
NCT00205777 (Bazedoxifene Acetate)
Cardiovascular & Alzheimer's Disease
NCT01763866 (Evolocumab)
NCT01763905 (Evolocumab)
NCT01687998 (Evacetrapib)
NCT01872598 (Masitinib)